Navigation Links
NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
Date:11/20/2007

SOPHIA ANTIPOLIS, France, Nov. 20 /PRNewswire/ -- NicOx S.A. (Eurolist: COX) today announced that TOPIGEN Pharmaceuticals Inc. has dosed the first patients in a phase 2 proof of concept study for TPI 1020 in Chronic Obstructive Pulmonary Disease (COPD) - see TOPIGEN press release attached. This new study is expected to provide the first assessment of TPI 1020's potential activity in COPD. TPI 1020 is a new chemical entity and novel anti- inflammatory licensed by TOPIGEN from NicOx for COPD and other respiratory disorders.

This new clinical study follows the recent announcement of promising top- line results from a phase 2a study in asthmatic smokers, where TPI 1020 showed a good safety and tolerability profile, in addition to certain anti- inflammatory effects which could be potentially beneficial in COPD (see press release of September 11, 2007). COPD is a respiratory disease caused by chronic inflammation of the lungs and bronchi and represents the third-leading cause of death in the United States (see NOTE).

Pascal Pfister, Chief Scientific Officer at NicOx, said: "We believe TPI 1020, which has a novel mechanism of action due to NicOx technology, could have the potential to bring real benefits to people suffering from COPD, based on data that has been observed in preclinical studies and the recently reported asthmatic smoker safety study. The progression of the TPI 1020 program is a testament to TOPIGEN's expertise in the respiratory therapeutic area, as well as the broad potential of NicOx' technology, and we see this collaboration as a validation of our strategy of partnering with leading biopharmaceutical companies outside our key therapeutic domains. We look forward to the results of this phase 2 proof of concept study, which should provide an important assessment of the compound's activity."

Under the terms of the agreement signed between NicOx and TOPIGEN in October 2005, TOPIGEN acquired the development and commercialization right
'/>"/>

SOURCE NicOx
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. NicOx Naproxcinod ABPM Data Presented at American Heart Association
4. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...A, Calif., Nov. 25 AMPAC Fine Chem...Corporation (Nasdaq: APFC ) announced today that ...ustainability Award at the Annual Statewide Enviro...cturers and Technology Association (CMTA), the Ind...emical Industry Council of California (CICC) held ...
(Date:11/25/2009)...K, Nov. 25 Reportlinker.com announ... in its catalogue: ,, Mammography Equipment -...eportlinker.com/p0164330/Mammography-Equipment---A...dence of breast cancer in industrialized as well a...cing growth in the mammography market. Globally, e...
(Date:11/25/2009)...IEGO, Nov. 25 NuVasive, ...cused on developing products for minimally disrupt...oday that it will host a conference call on Monday...T. The conference call will focus on current issu...ducts and will include comments from management fo...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Chimerix Raises 2416 1 Million in Series E Financing 54158 1Chimerix Raises 2416 1 Million in Series E Financing 54158 2Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 1Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 2New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 1New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 2New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 3
..., - Largest Genomic Study Comparing Gene Expressio...nual Meeting - , , ORLANDO, Fla., May 29 Genomic...sults from a study which summarized the gene signa...ncer test in a large number of male patients for w...otherapy. The results, which will be presented in ...
..., Panel Votes in Favor of Use by Physician/Nurse T...ion , , CINCINNATI, May 28 Ethicon Endo-Surgery ...atory Therapy Devices Advisory Committee of the U....or of approval of the SEDASYS(R) System for use by...derate propofol sedation during screening and diag...
Other Medicine Technology:Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5FDA Advisory Panel Recommends Approval of the SEDASYS(R) System 2FDA Advisory Panel Recommends Approval of the SEDASYS(R) System 3
(Date:11/27/2009)... XenaCare Holdings has announced that it ...ndation, one of the largest nonprofit organization...h education. , Delray Bea...ngs, Inc. (OTCBB: XCHO), a company specializing in... healthcare products, has announced today that is ...
(Date:11/27/2009)... Voyant Health™ announced today tha...ensed its TraumaCad Enterprise orthopedic templati...tion. , (PRWEB) November ...hat Spectrum Health (Grand Rapids, Michigan) has l...ting solution and its TraumaCad Extend workflow so...
(Date:11/26/2009)...YORK, Nov. 27 With cold and flu se...loy good practices to control the spread of infect...tive not only to keep ourselves healthy, but to av...en Finerty, RN, MS, CIC (certified in infection-co... occupational health at Hospital for Special Surge...
(Date:11/26/2009)...oo big or too heavy can lead to strains or worse ,... There may be nothing wrong with stuffing your tur... the same thing with your suitcase as you pack for...treated in 2008 in U.S. hospital emergency rooms, ...ties for luggage-related injuries, such as muscle ...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a l...lina, today announced the expansion of its service...tist, Dr. Doug Macmillan. , ...al is pleased to announce that Dr. Doug Macmillan,...leted an additional advanced training seminar. RT...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...th autism were roughly twice as likely to have bee...zophrenia, than parents of other children, accordi...cords by a University of North Carolina at Chapel ...ffspring, appears in the May 5, 2008, issue of the...
...e-FirstCall/ -- China Sky One,Medical, Inc. ("Chin...,Board: CSKI), a leading fully integrated pharmace...drugs in the People,s Republic of China,("PRC"), t...ompany Limited ("First"), a wholly-owned,subsidiar...
...ing waist line, weight gain and a tendency to deve... a study published today in the journal Nature Gen...ence is significantly more common in those with In...cientists from Imperial College London and other i...
...at 2008 Annual Meeting in San,Diego, CA, NEW YORK..., is the new President of the American Society for...Society, with nearly 2,400,members, is the leading...d on May 4, during the ASAPS 2008 Annual,Meeting i...
...assumptions, children are more vulnerable to the h...an they are in early childhood, according to a Cin... be presented May 4 at the annual meeting of the P... pediatricians should be just as, if not more conc...
...ion costs, BROOKLYN, N.Y., May 3 Thirty-five wom... early Mother,s Day today by building,affordable h...wn these,homes in the future., Sponsored by Habit...a low-income neighborhood and honor mothers,everyw...
Other Medicine News:Health News:Mental disorders in parents linked to autism in children 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 3Health News:Gene sequence that can make half of us fatter is discovered 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 3Health News:Children more vulnerable to harmful effects of lead 2Health News:Women Volunteers Celebrate Mother's Day Early by Building Affordable Homes for New York City Families 2
ACCU-Beam® Coolpix Digital Camera Adaptor (30mm Eyepiece Adaptor)
ACCU-Beam® Universal Digital Camera Adaptor (Dual Adaptor)
ACCU-Beam® Universal Digital Camera Adaptor (23mm Eyepiece)
...cope Accessories includes digital camera adaptors,...les, and fiberoptic retrofits. The ACCU-Beam® ...a Zeiss® style beamsplitter port. Beamsplitter... other brands of microscopes, colposcopes and slit...
Medicine Products: